News » Page 26 of 329 » Sonn Law Group

Investor Alert: Four Springs Capital 1031 Exchange Investments – Illiquidity Risks, Withdrawn IPO, and Potential FINRA Claims

By Jeffrey Sonn|2026-04-10T09:34:51-04:00April 10th, 2026|Investor Alerts|

Four Springs Capital Trust and its affiliated 1031 Exchange Delaware Statutory Trust (DST) offerings are drawing increased scrutiny as investors face ongoing liquidity constraints and uncertainty surrounding exit opportunities. Public filings and market data confirm that Four Springs Capital has repeatedly postponed and ultimately withdrawn its planned public offering, raising important questions about valuation, investor [...]

Investor Alert: Super Micro Computer, Inc. – Filing Delays and Accounting Scrutiny Raise Investor Concerns

By Jeffrey Sonn|2026-04-10T09:12:43-04:00April 10th, 2026|Investor Alerts|

Overview: Investors in Super Micro Computer, Inc. (NASDAQ: SMCI) are facing renewed uncertainty following delayed financial filings and increasing scrutiny surrounding the company’s internal controls and disclosures. What Happened Super Micro Computer recently disclosed that it would delay the filing of its annual financial report, raising concerns about the company’s accounting practices and internal controls [...]

Investor Alert: GoDaddy, Inc. – Securities Fraud Investigation Underway

By Jeffrey Sonn|2026-04-10T09:02:27-04:00April 10th, 2026|Investor Alerts|

Investors in GoDaddy, Inc. (NYSE: GDDY) are being alerted to a newly announced securities fraud investigation into whether the company made materially misleading statements about its business operations and financial outlook. What Happened GoDaddy is currently under investigation by shareholder rights law firms for potential violations of federal securities laws. The inquiry focuses on whether [...]

Investor Alert: ADMA Biologics Securities Fraud Investigation After 29% Stock Decline

By Jeffrey Sonn|2026-04-10T08:57:50-04:00April 10th, 2026|Investor Alerts|

Overview: Investors in ADMA Biologics, Inc. (NASDAQ: ADMA) have incurred significant losses after a sharp stock decline linked to allegations of securities fraud related to revenue reporting. Background ADMA Biologics is currently under investigation by multiple law firms for potential violations of federal securities laws. (https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-adma-biologics-inc---adma-302737867.html) The investigation focuses on whether the company and its [...]

Investor Alert: Kenneth Carl Ramos Customer Complaints and Termination Signal Potential Investor Risk

By Jeffrey Sonn|2026-04-10T08:45:39-04:00April 9th, 2026|Investor Alerts|

Investors who worked with Kenneth Carl Ramos should review their accounts in light of recent public disclosures regarding customer complaints and a prior employment separation. BrokerCheck reports multiple customer disputes and a termination-related event that may require further attention (BrokerCheck: Kenneth Carl Ramos — https://brokercheck.finra.org/individual/summary/2553426). Significance of These Disclosures Patterns of complaints and termination may [...]

Investor Alert: SEC Lawsuit Alleges $1.8M Fraud Scheme Involving Castle Hill Advisor

By Jeffrey Sonn|2026-04-09T11:29:50-04:00April 9th, 2026|Investor Alerts|

The U.S. Securities and Exchange Commission has filed an enforcement action alleging investor fraud involving John R. Brodacki III, a former advisor at Castle Hill Financial Group. This case highlights a recurring and concerning pattern in the securities industry:Trusted advisors allegedly divert client funds under the pretense of legitimate investment strategies, often targeting vulnerable investors. [...]

Investor Alert: Vincent Camarda Case Presents Significant Recovery Opportunities for Impacted Investors

By Jeffrey Sonn|2026-04-09T11:17:34-04:00April 9th, 2026|Investor Alerts|

Recent developments available through FINRA BrokerCheck involving Vincent Camarda (CRD# 1372052) have attracted heightened attention from regulators, arbitration panels, and investor advocates due to multiple customer complaints, regulatory actions, and substantial financial awards related to his conduct. Investors who have experienced losses may have a significant opportunity to seek recovery through FINRA arbitration and related [...]

Stirlingshire Investments FINRA Action: Leveraged ETF Violations and Investor Risk

By Jeffrey Sonn|2026-04-09T11:13:50-04:00April 9th, 2026|Broker / Advisor Investigations|

Recent disciplinary action by FINRA highlights compliance failures at Stirlingshire Investments involving recommendations of complex exchange-traded products to retail investors. According to FINRA, the firm failed to establish and enforce supervisory procedures related to the recommendation of inverse and leveraged ETFs, products that carry elevated risk and are generally intended for short-term trading strategies.Key Findings [...]

Independence Capital FINRA Action: Speculative Bond Sales to Retail and Senior Investors

By Jeffrey Sonn|2026-04-09T10:57:39-04:00April 9th, 2026|Broker / Advisor Investigations|

Recent FINRA action highlights serious concerns about Independence Capital Co., Inc. related to selling high-risk bonds to retail investors, including seniors. FINRA found the firm failed to reasonably supervise recommendations involving speculative, illiquid GWG L Bonds, suitable only for investors with substantial financial resources and no liquidity needs. Key Findings FINRA found that: Approximately $443,000 [...]

1-844-689-5754

LATEST NEWS & UPDATES

Timely insights on securities fraud, investor recovery, and financial misconduct.

From strategy to impact.

Contact Info